Concord Biotech IPO Subscription Day 1: Rakesh Jhunjhunwala’s RARE Enterprises-backed Concord Biotech’s initial public offering (IPO) has opened for subscribers today and it will remain open for bidders till 8th August 2023. The public issue aims to raise Rs 1,551 crore and the book build issue is completely offer for sale (OFS) in nature. The…
Concord Biotech IPO Subscription Day 3: Rakesh Jhunjhunwala’s RARE Enterprises-backed Concord Biotech’s initial public offering (IPO) has been fully subscribed on day 2 as it received strong demand from retail as well as non-institutional investors. The Concord Biotech IPO has been subscribed 2.72 times in total as the issue received bids for 3.97 crore equity shares as…
Concord Biotech IPO Subscription Day 2: Rakesh Jhunjhunwala’s RARE Enterprises-backed Concord Biotech’s initial public offering (IPO) was subscribed 0.61 times on Day 1. Rekha Jhunjhunwala-owned RARE Enterprises holds 24.09 per cent stake in Concord Biotech. The public offer had opened for subscribers on Friday, August 4 and it will remain open for bidders till 8th August 2023. The public issue…